At a glance
In this webinar, you will learn about the health effects evaluation process in the ATSDR public health assessment (PHA) process. You will discover how to incorporate health outcome data into the PHA and explore the concept of exposure units. Lastly, you will gain a clear understanding of how to estimate exposure point concentrations using both discrete sampling and non-discrete sampling methods.
Training objectives
At the conclusion of the Public Health Assessment Webinar: Exposure Units and Estimating Exposure Point Concentrations, you will be able to:
- Describe the health effects evaluation process.
- Analyze potential uncertainties in the health effects evaluation.
- Explain how to incorporate health outcome data into the PHA process.
- Identify how defining exposure units fits into the public health evaluation process.
- Identify how estimating exposure unit concentrations (EPCs) fits into the public health evaluation process.
- Explain EPCs for either discrete or non-discrete sampling.
- Describe ATSDR's team and multidisciplinary approach to the health effects evaluation.
Target audience
Public health professionals involved or interested in the PHA process, including:
- Environmental Health Specialists, Toxicologists, and Epidemiologists
- Health educators, Health Communicators and Community Involvement Specialists
- Medical Officers and Registered Nurses
- Program Managers
Continuing education units
Instructions for Obtaining Continuing Education (CE)
To receive CE for WD4746- Public Health Assessment Webinar: Exposure Units and Estimating Exposure Point Concentrations, you must complete the steps below by March 21, 2026. Use the "WD4746" course number to search for this course.
- Check the box for each type of CE you wish to apply for when registering for the course.
- Complete the course.
- If there is a Mark Completed button on the course page in TRAIN, click to move to the next step.
- Pass the post-assessment. You will have 2 attempts to pass.
- Complete the evaluation.
You can access your certificates and transcript by visiting Your Learning in TRAIN.
Prerequisites
There are no prerequisites for this webinar, but we recommend studying the Public Health Assessment Training Module 7: Health Effects Evaluation.
Faculty/Credentials
- Rebecca DeVries, ScD, Epidemiologist, Eastern Research Group, Inc.
- James T. Durant, MSPH BS CIH, Environmental Health Scientist, ATSDR/OCHHA/EIS
- David Mellard, PhD, Associate Director for Science, ATSDR/OCDAPS/ADS
Accreditation Statements
CME (Continuing Medical Education): The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE (Continuing Nursing Education): The Centers for Disease Control and Prevention designates this activity for 1.5 nursing contact hours.
CEU (Continuing Education Unit): The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU's for this program.
CECH (Continuing Education Contact Hours): Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.5. Continuing Competency credits available are 1.5. CDC provider number 98614.
CPH (Certified in Public Health): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 2.0 CPH recertification credits for this program.
Disclosure
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.